Vor Biopharma (VOR) Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non-Current Assets data on file, last reported at $6.0 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $6.0 million, down 86.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.2 million (down 91.52% YoY), and the FY2025 annual result was $6.0 million, down 87.02% from the prior year.
• Non-Current Assets declined to $6.0 million in Q1 2026 per VOR's latest filing, from $6.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $65.8 million in Q2 2022 and troughed at $444000.0 in Q2 2025.
• A 5-year average of $43.2 million and a median of $51.3 million in 2024 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 154.16% in 2022, then plunged 99.14% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $62.4 million in 2022, then retreated by 8.16% to $57.3 million in 2023, then slipped by 19.08% to $46.4 million in 2024, then plunged by 87.02% to $6.0 million in 2025, then dropped by 0.88% to $6.0 million in 2026.
• Business Quant data shows VOR's Non-Current Assets at $6.0 million in Q1 2026, $6.0 million in Q4 2025, and $3.8 million in Q3 2025.